| Value | ₹0.73 Cr |
|---|
BSE filing, NSE: SUVEN. Summary written from the filing by ALFA Finder's alert engine.
Suven Life Sciences Ltd: key numbers
- Share price
- ₹271.75
- Market cap
- ₹7,679 Cr
- Revenue (annual)
- ₹7.11 Cr
- Net profit (annual)
- ₹-276.3 Cr
- P/E (TTM)
- -21.8×Sector 53.7×
- Promoter holding
- 65.47%-4.61% QoQ
- FII holding
- 0.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suven Life Sciences Ltd
All →Suven Life Sciences Board Meeting Date
Suven Life Sciences scheduled its board meeting for 5 November 2026 to approve Q1 and H1 FY27 unaudited results. The trading window closed from 1 October 2026 until 48 hours post-declaration.
Suven Life Sciences Other Announcement
Suven Life Sciences Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI regulations.
Suven Life Sciences Business Update
Suven Life Sciences has completed patient enrollment for its global Phase-3 clinical study of Masupirdine. A total of 424 patients were randomized across the USA and Europe.
- clinical trial enrollment
- 424.0 patients
Suven Life Sciences Annual General Meeting
Suven Life Sciences held its 37th Annual General Meeting on August 25, 2026. The company submitted the proceedings, scrutineer's report, and voting results.
Suven Life Sciences Other Announcement
Suven Life Sciences Limited submitted its Monitoring Agency Report for the quarter ended June 30, 2026. The report confirms the utilization of Rs. 857.64 Crore raised via preferential issue.
- Value
- ₹857.6 Cr
Suven Life Sciences Q1 FY27 Results: Net Loss of ₹127.6 Cr, Loss Widens
Suven Life Sciences Ltd reported revenue from operations of ₹3.6 Cr (+89.5% YoY) and a net loss of ₹127.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹127.6 Cr
Other employee stock options announcements
All →Digitide Solutions Employee Stock Options
Digitide Solutions allotted 281,089 equity shares to RSU holders under its Special Purpose SOP 2025 employee plan. Paid-up capital rises to 149,460,919 shares, with no cash consideration stated.
Lloyds Engineering Works Employee Stock Options
Lloyds Engineering allotted 2,55,697 equity shares under its ESOP 2021 at a Rs 9.50 exercise price. Vesting begins January 2027, and no exercise proceeds have been received yet.
Aditya Birla Fashion and Retail Employee Stock Options
ABFRL's postal ballot passed two special resolutions adopting the ABFRL ESOP Scheme 2026 and extending it to subsidiary employees. Both cleared with over 96% of votes polled.
Physicswallah Employee Stock Options
Physicswallah granted 1,84,828 ESOP 2025 options to eligible employees. Each option converts into one equity share at an exercise price of INR 1.
Manipal Payment and Identity Solutions Employee Stock Options
Manipal Payment sought postal ballot approval to amend, rename and ratify its ESOP 2024 scheme. Item three extends the scheme to group company employees.
RSWM Employee Stock Options
RSWM Limited instituted its 2026 ESOP scheme, granting 9,70,000 options at Rs.146 exercise price. Employees may exercise them after vesting, over up to four years.
- Execution
- Exercise over a maximum of 4 years from each vesting date; vesting over 1 to 4 years from grant